Abstract
The incidence of somatic mutagenesis of p53 oncosuppressor protein in malignant tumors of the stomach and genetic polymorphism of p53 were studied in patients with stomach cancer on DNA samples isolated from tumor tissues obtained during surgery. The incidence of Pro/Pro genotype increased in the patients, while the percentage of Arg/Pro heterozygotes was markedly lower compared to long-living persons without cancer. The incidence of p53 somatic mutations in exons 5, 7, 8 was 70.8%; multiple mutations were detected in half of the examined patients. The relationship between the intensity of p53 mutagenesis and histological structure of the tumor was detected. The contribution of p53 genetic status to the risk of stomach cancer can be more effectively evaluated on DNA samples isolated from not only tumor cells, but also from normal tissues. The effects of epigenetic factors determining the intensity of somatic mutagenesis of p53 in tumors should be taken into account.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. I. Chissov and S. L. Dar’yalova, Selected Lectures in Clinical Oncology [in Russian], Moscow (2000).
V. V. Lyakhovich, V. A. Vavilin, N. I. Gutkina, et al., Vopr. Med. Khim., No. 5, 330–338 (1997).
S. Harrington and J. Macgui, Molecular Clinical Diagnosis. Methods [in Russian], Moscow (1999).
N. A. Smetannikova, M. A. Smetannikova, V. A. Belyavskaya, et al., Sibirsk. Onkol. Zh., Nos. 2–3, 124–128 (2004).
M. Bonafe, C. Ceccarelli, F. Farabegoli, et al., Clin. Cancer Res., 9, No. 13, 4860–4864 (2003).
J. Breton, F. Sichel, A. Abbas, et al., Mutagenesis, 18, No. 3, 299–306 (2003).
Paula P. Magalhaes, Carcinogenesis, 24, 145 (2003).
C. Prives, Cell, 78, No. 4, 543–546 (1994).
G. N. Ranzani, O. Luinetti, L. S. Paolovan, et al., Cancer Epidemiol. Biomarkers Prev., 4, No. 3, 223–231 (1995).
S. N. Rodin and A. S. Rodin, Proc. Natl. Acad. Sci. USA, 95, 11,927–11,932 (2001).
R. Schneider-Stock, Am. J. Pathol., 164, No. 4, 1233–1241 (2004).
A. Storey, M. Thomas, A. Kalita, et al., Nature, 393, 229–234 (1998).
M. Thomas and A. Kalita, Mol. Cell. Biol., 19, 1092–110 (1999).
Y. C. Wang, C. Y. Chen, S. K. Chen, et al., Clin. Cancer Res., 5, No. 1, 129–134 (1999).
Z.-W. Zhang, N. J. Laurence, A. Hollowood, et al., Clin. Cancer Res., 10, No. 1, Pt. 1, 131–135 (2004).
Author information
Authors and Affiliations
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 141, No. 2, pp. 205–209, February, 2006
Rights and permissions
About this article
Cite this article
Belyavskaya, V.A., Vardosanidze, V.K., Smirnova, O.Y. et al. Genetic status of p53 in stomach cancer: Somatic mutations and polymorphism of codon 72. Bull Exp Biol Med 141, 243–246 (2006). https://doi.org/10.1007/s10517-006-0139-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-006-0139-7